CXCL8 and serous adenocarcinoma: To begin to determine the clinical relevance of our findings, we performed fluorescent immunohistochemistry of IL8 and HE4 in serous adenocarcinoma EOC tissue (n = 40) and normal adjacent tissue (NAT; n = 8) in an EOC tissue microarray.